CACIPLIQ20 Spray 7.5 ml RGTA skin healing solution for chronic wounds

CACIPLIQ20® Spray 7.5 ml RGTA® - Skin healing solution for chronic wounds

Renewal matrix treatment

CACIPLIQ20® is an RGTA® (ReGeneraTing Agent), intended to improve the healing of chronic skin ulcers by promoting recovery of the extracellular matrix, while reducing pain resulting from the lesion.

It is indicated in chronic skin pressure ulcers resulting from arterial disease, peripheral disease (such as stage IV in the classification of Leriche and Fontaine) or diabetes (including amputation), which show no tendency to heal after 6 months of usual care or continued after 12 months. Months.

treatment:

CACIPLIQ20® is intended for application twice a week (every 3-4 days), ideally at the time of dressing change. Frequent use may reduce the therapeutic effect. Results may vary from patient to patient, your doctor can adapt the duration of treatment accordingly. Results should usually appear after 3 months of use.

contraindications:

Do not use in patients with a history of allergy or anaphylactic reactions to any of the ingredients or to heparinoid compounds.

Users:

CACIPLIQ20® is best applied to a wound that has been cleaned by surgical debridement by a health care professional. CACIPLIQ20® is also effective when applied to a clean wound, without exudate, fibrous clot or necrotic tissue, either directly by the patient or by the caregiver. CACIPLIQ20® is used under the supervision of a healthcare professional.

maintain:

Store in a dry place between 2°C and 25°C. Momentary and occasional exposure to higher temperatures (below 40°C) does not affect the safety of the product. Do not use after the expiry date indicated on the package. Do not use if bottle or spray tip is damaged and not sterile. Use within 6 months after first use.

Warnings:

In the absence of clinical data, it is recommended not to use CACIPLIQ20® in pregnant or lactating women, and in patients under 18 years of age. Choking Hazard - Keep out of the reach and sight of children. CACIPLIQ20® bottles and care kits do not contain preservatives and are for single use. The product will no longer be sterile if reused. To avoid contamination, do not reuse or attempt to re-sterilize. Do not pour the solution directly onto the wound. Do not inject. Do not swallow (if so, rinse mouth with water) or use in any way not prescribed (see instructions).

Respect the prescribed dose: if CACIPLIQ20® is applied too frequently, the therapeutic effect may be reduced. Control any potential infection and clean the wound before treatment. Do not use it on dead tissue. Do not use on severely suppurating wounds. Do not use in patients with a history of hypersensitivity to any of the components or to heparinoid compounds. People allergic to heparinoids may experience local reactions (redness, local swelling, pain, etc.), which should not affect the healing process. If symptoms persist or worsen, discontinue use and seek advice from your doctor.

CACIPLIQ20® is not indicated for patients eligible for revascularization surgery. CACIPLIQ20® is not indicated for patients using a non-removable boot to treat diabetic foot ulcers. Based on chemical reaction studies and literature, CACIPLIQ20® should not be used with:

- Topical antibiotics from the aminoglycoside family (gentamicin, neomycin, etc.).

- Solutions containing silver, iodine, copper or gold salts or polycation-based products such as disinfectants that contain quaternary ammonium (eg benzalkonium chloride) already, these ions can immobilize the molecule.

Shop more from Diabetic Foot & Bed Sores